Skip to main content
Erschienen in: Rheumatology International 10/2021

09.03.2021 | Case Based Review

Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review

verfasst von: Reşit Yıldırım, Döndü Üsküdar Cansu, Deniz Arık, Suzan Saylısoy, Cengiz Korkmaz

Erschienen in: Rheumatology International | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.
Literatur
2.
Zurück zum Zitat Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94CrossRefPubMed Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP (2020) Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment. Neurohospitalist 10(2):88–94CrossRefPubMed
3.
Zurück zum Zitat Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510CrossRef Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P (2018) Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res ClinRheumatol 32(4):500–510CrossRef
5.
Zurück zum Zitat Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346PubMed Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, Khanna D (2006) Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol 33(11):2344–2346PubMed
6.
Zurück zum Zitat Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206 Seago S, Stroberg E, Metting A (2016) Rheumatoid meningitis associated with infliximab. Proc (BaylUniv Med Cent) 29(2):204–206
7.
Zurück zum Zitat Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212CrossRef Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol 28(13):212CrossRef
8.
Zurück zum Zitat Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183 Wright WF, Pinto CN, Palisoc K, Baghli S (2019) Viral (aseptic) meningitis: a review. J NeurolSci 398:176–183
9.
Zurück zum Zitat Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417CrossRef Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. RheumatolInt 31:1409–1417CrossRef
10.
Zurück zum Zitat Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808CrossRefPubMed Gherghel N, Stan A, Stan H (2018) Pearls & Oy-sters: rheumatoid meningitis occurring during treatment with etanercept. Neurology 91(17):806–808CrossRefPubMed
11.
Zurück zum Zitat Koopmansch C, D’Haene N, Hastir D, Sadeghi N, Maris C, Salmon I (2016) A 63-year-old woman with a right frontal lesion. Brain Pathol 26(4):555–556CrossRefPubMedPubMedCentral Koopmansch C, D’Haene N, Hastir D, Sadeghi N, Maris C, Salmon I (2016) A 63-year-old woman with a right frontal lesion. Brain Pathol 26(4):555–556CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92CrossRefPubMed Huys AC, Guerne PA, Horvath J (2012) Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine 79(1):90–92CrossRefPubMed
13.
Zurück zum Zitat Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116CrossRefPubMedPubMedCentral Chou RC, Henson JW, Tian D, Hedley-Whyte ET, Reginato AM (2006) Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab. Ann Rheum Dis 65(8):1114–1116CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314 Nihat A, Chinthapalli K, Bridges L, Johns P, Sofat N, Moynihan B (2016) Rheumatoid meningitis. PractNeurol 16(4):312–314
15.
Zurück zum Zitat Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83 Qin Z, Kim J, Valencia D, Hamoodi L, Neltner J, Sizemore T, Lightfoot R Jr (2020) Rheumatoid meningitis: a case report and review of the literature. NeurolClinPract 10(1):73–83
16.
Zurück zum Zitat Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784CrossRefPubMed Marotte H, Charrin JE, Miossec P (2001) Infliximab-induced aseptic meningitis. Lancet 358(9295):1784CrossRefPubMed
17.
Zurück zum Zitat Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8) Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. ClinExpRheumato 32(5):732–734 (Epub 2014 Sep 8)
18.
Zurück zum Zitat Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625CrossRefPubMedCentral Trabelsi M, Romand X, Gilson M, Vaillant M, Guerne PA, Hayem G, Bertolini E, Baillet A, Gaudin P (2020) Rheumatoid meningitis a rare extra-articular manifestation of rheumatoid arthritis: report of 6 cases and literature review. J Clin Med 9(6):1625CrossRefPubMedCentral
19.
Zurück zum Zitat Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619CrossRefPubMed Jazeron A, Lallier JC, Rihn B, Thiercelin MC (2010) Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine 77(6):618–619CrossRefPubMed
20.
Zurück zum Zitat Booker MJ, Flint J, Saravana S (2008) Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report. Cases J 1(1):364CrossRefPubMedPubMedCentral Booker MJ, Flint J, Saravana S (2008) Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report. Cases J 1(1):364CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260PubMedPubMedCentral Figueroa Rodriguez F, Minkyung K, Jinna S, Farshad S, Davila F (2018) Rheumatoid meningoencephalitis: a feared condition in the era of tnf blockers. Case Rep Rheumatol 2018:4610260PubMedPubMedCentral
22.
Zurück zum Zitat Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132 Matsushima M, Yaguchi H, Niino M, Akimoto-Tsuji S, Yabe I, Onishi K, Sasaki H (2010) MRI and pathological findings of rheumatoid meningitis. J ClinNeurosci 17(1):129–132
23.
Zurück zum Zitat Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080CrossRefPubMed Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68(13):1079–1080CrossRefPubMed
26.
Zurück zum Zitat Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634CrossRefPubMed Schmid L, Müller M, Treumann T, Arnold W, Möller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60(6):1632–1634CrossRefPubMed
27.
Zurück zum Zitat McKenna MC, Vaughan D, Bermingham N, Cronin S (2019) Rheumatoid arthritis presenting as rheumatoid meningitis. BMJ Case Rep 12(1):bcr-2018-226649CrossRefPubMedPubMedCentral McKenna MC, Vaughan D, Bermingham N, Cronin S (2019) Rheumatoid arthritis presenting as rheumatoid meningitis. BMJ Case Rep 12(1):bcr-2018-226649CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264PubMed Finkelshtein V, Lampl Y, Lorberboym M, Kanner A, Ben-Ami Raichman D, Dabby R, Tanay A (2018) Self-limited rheumatoid meningitis as a presenting symptom of rheumatoid arthritis. Isr Med Assoc J 20(4):262–264PubMed
29.
Zurück zum Zitat Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481 Li SY, Birnbaum AD, Goldstein DA (2010) Optic neuritis associated with adalimumab in the treatment of uveitis. OculImmunolInflamm 18(6):475–481
30.
Zurück zum Zitat Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874CrossRef Seror R, Richez C, Sordet C, Rist S, Gossec L, Direz G, Houvenagel E, Berthelot JM, Pagnoux C, Dernis E, Melac-Ducamp S, Bouvard B, Asquier C, Martin A, Puechal X, Mariette X; Club Rhumatismes et Inflammation Section of the SFR (2013) Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 52(5):868–874CrossRef
31.
Zurück zum Zitat Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946CrossRefPubMed Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A (2020) association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events. JAMA Neurol 77(8):937–946CrossRefPubMed
32.
Zurück zum Zitat Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260 Yelehe-Okouma M, Czmil-Garon J, Pape E, Petitpain N, Gillet P (2018) Drug-induced aseptic meningitis: a mini-review. FundamClinPharmacol 32(3):252–260
33.
Zurück zum Zitat Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132 Shapiro WR, Young DF (1984) Neurological complications of antineoplastic therapy. ActaNeurolScandSuppl 100:125–132
34.
Zurück zum Zitat Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911CrossRefPubMed Hawboldt J, Bader M (2007) Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother 41(11):1906–1911CrossRefPubMed
35.
Zurück zum Zitat Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682 Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Meningitetuberculosaduranteterapia com infliximab (Tuberculosis meningitis during infliximab therapy). ActaRheumatol Port 34(4):681–682
36.
Zurück zum Zitat Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85CrossRefPubMed Parsons AM, Zuniga LA, Hoxworth JM, Lyons M, Aslam F, Goodman BP (2018) Rheumatoid meningitis: a case review. Neurologist 23(3):83–85CrossRefPubMed
37.
Zurück zum Zitat Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36 Kemanetzoglou E, Andreadou E (2017) CNS demyelination with TNF-α blockers. CurrNeurolNeurosci Rep 17(4):36
38.
Zurück zum Zitat Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983CrossRefPubMed Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44(9):1977–1983CrossRefPubMed
Metadaten
Titel
Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review
verfasst von
Reşit Yıldırım
Döndü Üsküdar Cansu
Deniz Arık
Suzan Saylısoy
Cengiz Korkmaz
Publikationsdatum
09.03.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 10/2021
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04822-6

Weitere Artikel der Ausgabe 10/2021

Rheumatology International 10/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.